Coming soon: Drugs for weight loss have been used for a long time in practice, however recent developments prompted the need for this special edition. The goals of this collection are to discuss ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...

Researchers at CNIO have discovered that blocking the mitochondrial protein MCJ in brown fat increases heat production and leads to weight loss in obese mice, offering protection against ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...

Dr. Rajan explained, "If you think obesity is just about willpower, you don't fully understand this complex metabolic condition." He went on to clarify, "What Oprah is referring to here is called ...

are designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not ...

Obesity estimates for Aboriginal groups are based on single responses for Aboriginal identity. For the purposes of this report, the term "First Nations off-reserve " is used in lieu of "North American ...

Recently, an international commission proposed a revised definition of obesity that focuses on how ... BMI is such an ingrained part of clinical practice and research; I don’t think it will ...

EXCLUSIVE: We understand that Oscar-winning filmmaker Susanne Bier is in negations to helm Warner Bros‘ Practical Magic 2 for the studio. A deal isn’t done quite yet. The movie would reteam ...

The trial investigated the safety, tolerability, pharmacokinetics, and proof-of-concept after once-weekly subcutaneous administrations of amycretin in 125 people with overweight or obesity.

The phase 1b/2a study compared the GLP-1 and amylin receptor agonist to placebo in 125 people who are overweight or with obesity. Patients achieved an estimated weight loss of 9.7% on 1.25 mg ...